DT
RLAY icon

Diversified Trust’s Relay Therapeutics RLAY Stock Holding History

Diversified Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
+66,194
New +$961K 0.02% 423

Other funds holding RLAY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Diversified Trust's RLAY Position: Q2 2026 in Review

Diversified Trust opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 66,194 shares worth $1.24M. The stake represents 0.02% of the portfolio and ranks #423 among its holdings.

24 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Diversified Trust held 66,194 shares of Relay Therapeutics worth $1.24M as of Q2 2026.
  • Relay Therapeutics was a new Diversified Trust position in Q2 2026.
  • Relay Therapeutics made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #423 holding.
  • 24 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.